Abstract
BackgroundWe have previously shown that a direct intratumoral (IT) injection of the hu14.18-IL2 immunocytokine (IC), an anti-GD2 antibody linked to interleukin 2, can serve as an in situ vaccine and...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have